KARACHI:

The Pakistan Pharmaceutical Manufacturers Association (PPMA) has raised serious concerns over the uncertainty surrounding the government's recent move to commission a third-party survey through the Drug Regulatory Authority of Pakistan (DRAP) on Prime Minister Shehbaz Sharif's directives, following public outcry over rising medicine prices after deregulation.

The Special Investment Facilitation Council (SIFC) convened an emergent meeting with PPMA in Islamabad, attended by PPMA Chairman Tauqeerul Haq, vice chairman, and Executive Director Col Nayyar. The SIFC team, led by its director general, was joined by Special Assistant to the Prime Minister on Industries, Haroon Akhtar. Opening the session, the PPMA chairman thanked SIFC for endorsing amendments to the drug law regarding d

See Full Page